NT-proBNP eGFR-CysC诊断CRF患者心功能不全的临床价值分析

doi:10.3969/j.issn.1006-6233.2018.10.031

Abstract
Figure/Table
References
Related Citation (7)

Download: PDF (1447 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To explore the early diagnostic efficacy of NT-proBNP and eGFR-CysC in patients with chronic renal failure complicated with cardiac insufficiency. Methods: A total of 147 patients with chronic renal failure diagnosed in our department from December 2015 to August 2017 were selected as the study subjects. 83 patients with cardiac insufficiency included in the study group, and the remaining 64 patients without cardiac insufficiency were treated as control group. Their baseline data, left ventricular end-diastolic diameter (LVDd), left atrial diameter (LADd), left ventricular ejection fraction (LVEF), troponin (cTnI), NT-proBNP, glomerular filtration rate (CysC) and eGFR-CysC were recorded. Univariate analysis and multivariate unconditional logistic regression were applied to select the factor that may affect chronic heart failure complicated with cardiac insufficiency. The relationship between eGFR-CysC and NT-proBNP was analyzed by Pearson analysis and ROC curve was used to show the sensitivity and specificity of above indicators in the diagnosis of patients with chronic renal failure complicated with cardiac insufficiency. Results: Univariate analysis showed that the levels of LVDd, cTnI, NT-proBNP, and CysC in patients with cardiac insufficiency were higher than those in control group; while the levels of LVEF and eGFR-CysC were lower than those in control group, and the differences were statistically significant (P<0.05); Multivariate Logistic regression analysis showed low LVEF, high NT-proBNP and Low levels of eGFR-CysC were risk factors for cardiac insufficiency in patients with renal failure. Pearson correlation analysis showed that the increase of eGFR-CysC was negatively correlated with the increase of NT-proBNP (r=-0.665, P=0.002). The AUC of eGFR-CysC under the ROC curve was the highest, with a specificity of 79.67% and a sensitivity of 82.89%. Conclusion: eGFR-CysC has a good diagnostic effect on patients with chronic renal failure complicated with cardiac insufficiency. It is expected to be used as one of the early detection indicators of cardiac insufficiency in patients with chronic renal failure.

Key words： NT-proBNP eGFR-CysC Chronic renal failure Cardiac insufficiency

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	SONG Jiazhi
	LIU Jing
	et al

Cite this article:

SONG Jiazhi,LIU Jing,et al. Clinical Value Analysis of NT-proBNP and eGFR-CysC in Diagnosis of Cardiac Insufficiency in CRF Patients[J]. HeBei Med, 2018, 24(10): 1711-1714.

URL:

http://www.hbyxzzs.cn/EN/10.3969/j.issn.1006-6233.2018.10.031 OR http://www.hbyxzzs.cn/EN/Y2018/V24/I10/1711

[1] Al-Kindi S G, Oliveira G H, Robinson M R. Resting heart rate and incident heart failure in patients with chronic kidney disease: analysis of the chronic renal insufficiency cohort (CRIC)[J]. Journal of Cardiac Failure, 2017, 23(8):S75.
[2] Cao R, Bai Y, Xu R, et al. Association between resting heart rate and N-terminal pro-brain natriuretic peptide in a community-based population study in Beijing[J]. Clinical Interventions in Aging, 2015, 10(default):55~60.
[3] Cheng H, Fan W Z, Wang S C, et al. Prognostic utility of combination of NT-proBNP with high sensitive cTn I in patients with heart failure: Results from retrospective study in an emergency department [J]. Scandinavian Journal of Clinical & Laboratory Investigation, 2016, 76(5):361~367.
[4] 邢晓博, 刘福颂,王芳,等.肥厚型心肌病心肌肌钙蛋白C基因TNNC1c.G175C突变一家系[J].中华心血管病杂志,2016,44(12):1020~1023.
[5] 何流,陈世银,陈志富,等.血清胱抑素C及其估算肾小球滤过率在亚临床肝肾综合征诊断中的应用[J].现代生物医学进展,2016,16(34):6742~6745.
[6] 韩辉,林书典,陈道军,等.基于肌酐和胱抑素C的肾小球滤过率评估方程在老年糖尿病肾病患者的适用性研究[J].肾脏病与透析肾移植杂志,2016,25(6):519~525.
[7] Barr E, Reutens A, Magliano D, et al. Cystatin C estimated glomerular filtration rate and all-cause and cardiovascular disease mortality risk in the general population: AusDiab study[J]. Nephrology, 2016, 22(3).
[8] 杨渝伟,曾平,张林,等.慢性肾病患者基于血清胱抑素C与肌酐的肾小球滤过率估算方程的建立和评价[J].中华检验医学杂志,2013,36(4):352~359.
[9] Wu D, Luo N, Wang L, et al. Hydrogen sulfide ameliorates chronic renal failure in rats by inhibiting apoptosis and inflammation through ROS/MAPK and NF-κB signaling pathways [J]. Scientific Reports, 2017, 7(1):455.
[10] Mccullough P A, Roberts W C. Influence of chronic renal failure on cardiac Structure[J]. Journal of the American College of Cardiology, 2016, 67(10):1183.
[11] Shah R, Matthews G J, Shah R Y, et al. Serum fractalkine (CX3CL1) and cardiovascular outcomes and diabetes: findings from the chronic renal insufficiency cohort (CRIC) study[J]. American Journal of Kidney Diseases, 2015, 66(2):266~273.
[12] 杜春荔,杨秉潜.尿毒症微炎症状态与营养不良心血管并发症的影响因素分析[J].中西医结合心脑血管病杂志,2017,(20):2618~2620.
[13] 毕礼明,陈英兰.对慢性肾衰竭患者高同型半胱氨酸血症的认识[J].医学争鸣,2016,(1):12~15.
[14] 孙黎,於佳炜,项方方,等.慢性肾脏病非透析患者血清高敏心肌肌钙蛋白T的影响因素分析[J].中华肾脏病杂志,2015,31(12):887~892.